EBMT-EHA CAR-T 2019 | Anti-BCMA CAR T-cell therapy for multiple myeloma: latest studies

Alfred Garfall

Alfred Garfall, MD, MS University of Pennsylvania, Pennsylvania, PA, discusses the latest results looking at anti-BCMA CAR T-cell therapy for multiple myeloma. Dr Garfall was speaking at at the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video